|
1
|
Cruickshank AM, Fraser WD, Burns HJ, Van
Damme J and Shenkin A: Response of serum interleukin-6 in patients
undergoing elective surgery of varying severity. Clin Sci (Lond).
79:161–165. 1990.PubMed/NCBI
|
|
2
|
Ono S, Aosasa S and Mochizuki H: Effects
of a protease inhibitor on reduction of surgical stress in
esophagectomy. Am J Surg. 177:78–82. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Sakamoto K, Arakawa H, Mita S, et al:
Elevation of circulating interleukin 6 after surgery: factors
influencing the serum level. Cytokine. 6:181–186. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kato M, Suzuki H, Murakami M, Akama M,
Matsukawa S and Hashimoto Y: Elevated plasma levels of
interleukin-6, interleukin-8, and granulocyte colony-stimulating
factor during and after major abdominal surgery. J Clin Anesth.
9:293–298. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Sato N, Murakami K, Ishida K, Ikeda K and
Saito K: Pulmonary hypertension and polymorphonuclear leukocyte
elastase after esophageal cancer operations. Ann Thorac Surg.
51:754–758. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Salier JP, Rouet P, Raguenez G and Daveau
M: The inter-alpha-inhibitor family: from structure to regulation.
Biochem J. 315:1–9. 1996.
|
|
7
|
Fries E and Blom AM: Bikunin - not just a
plasma proteinase inhibitor. Int J Biochem Cell Biol. 32:125–137.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Mizon C, Balduyck M, Bonneterre JP and
Mizon J: Urinary trypsin inhibitory capacity determination: study
in patients with disseminated cancers. Bull Cancer. 70:266–270.
1983.PubMed/NCBI
|
|
9
|
Chawla RK, Rausch DJ, Miller FW, Vogler WR
and Lawson DH: Abnormal profile of serum proteinase inhibitors in
cancer patients. Cancer Res. 44:2718–2723. 1984.PubMed/NCBI
|
|
10
|
Gosset D, Mizon C, Savinel P, et al:
Clinical value of the determination of urinary antitrypsin
activity. Presse Med. 17:329–332. 1988.(In French).
|
|
11
|
Kuwajima S, Matsui T, Kitahashi S, et al:
Automated measurement of trypsin inhibitor in urine with a
centrifugal analyzer: comparison with other acute phase reactants.
Clin Biochem. 23:167–171. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Noie T, Sugawara Y, Harihara Y, et al:
Kinetics of urinary trypsin inhibitor in patients undergoing
partial hepatectomy. Scand J Gastroenterol. 36:410–416. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Piette AM, Saba J, Bernard N, et al:
Urinary trypsin inhibitory activity for the diagnosis of bacterial
infection: a prospective study in 690 patients. Eur J Med.
1:273–276. 1992.PubMed/NCBI
|
|
14
|
Yamada S, Takatsuka H, Takemoto Y, et al:
Urinary trypsin inhibitor concentration can predict the
immunological insult of chemotherapy and complications after bone
marrow transplantation. Bone Marrow Transplant. 27:195–199. 2001.
View Article : Google Scholar
|
|
15
|
Takeda S, Takeda S, Kim C, et al:
Preoperative administration of methylprednisolone attenuates
cytokine-induced respiratory failure after esophageal resection. J
Nippon Med Sch. 70:16–20. 2003. View Article : Google Scholar
|
|
16
|
Sato N, Koeda K, Ikeda K, et al:
Randomized study of the benefits of preoperative corticosteroid
administration on the postoperative morbidity and cytokine response
in patients undergoing surgery for esophageal cancer. Ann Surg.
236:184–190. 2002. View Article : Google Scholar
|
|
17
|
Bone RC, Fisher CJ Jr, Clemmer TP, Slotman
GJ, Metz CA and Balk RA: A controlled clinical trial of high-dose
methylprednisolone in the treatment of severe sepsis and septic
shock. N Engl J Med. 317:653–658. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Tonnesen E, Wanscher M, Hohndorf K, et al:
Effect of methylprednisolone on the cytokine response in patients
undergoing lung surgery. Acta Anaesthesiol Scand. 37:410–414. 1993.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Miyashita M: Controversy of
corticosteroids in septic shock. J Nippon Med Sch. 77:67–70. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
American College of Chest
Physicians/Society of Critical Care Medicine Consensus Conference:
Definitions for sepsis and organ failure and guidelines for the use
of innovative therapies in sepsis. Crit Care Med. 20:864–874. 1992.
View Article : Google Scholar
|
|
21
|
Swisher SG, Hunt KK, Holmes EC, Zinner MJ
and McFadden DW: Changes in the surgical management of esophageal
cancer from 1970 to 1993. Am J Surg. 169:609–614. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Isono K, Sato H and Nakayama K: Results of
a nationwide study on the three-field lymph node dissection of
esophageal cancer. Oncology. 48:411–420. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Fok M, Law SY and Wong J: Operable
esophageal carcinoma: current results from Hong Kong. World J Surg.
18:355–360. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kaumeyer JF, Polazzi JO and Kotick MP: The
mRNA for a proteinase inhibitor related to the HI-30 domain of
inter-alpha-trypsin inhibitor also encodes alpha-1-microglobulin
(protein HC). Nucleic Acids Res. 14:7839–7850. 1986. View Article : Google Scholar
|
|
25
|
Sugiki M, Sumi H, Maruyama M, Yoshida E
and Mihara H: Clearance and distribution of acid-stable trypsin
inhibitor (ASTI). Enzyme. 42:31–38. 1989.PubMed/NCBI
|
|
26
|
Mizon C, Piva F, Queyrel V, Balduyck M,
Hachulla E and Mizon J: Urinary bikunin determination provides
insight into proteinase/proteinase inhibitor imbalance in patients
with inflammatory diseases. Clin Chem Lab Med. 40:579–586. 2002.
View Article : Google Scholar
|
|
27
|
Kobayashi H: Endogenous anti-inflammatory
substances, inter-alpha-inhibitor and bikunin. Biol Chem.
387:1545–1549. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ogawa M, Nishibe S, Mori T and Neumann S:
Effect of human urinary trypsin inhibitor on granulocyte elastase
activity. Res Commun Chem Pathol Pharmacol. 55:271–274.
1987.PubMed/NCBI
|
|
29
|
Faarvang HJ and Lauritsen OS: Circadian
variations in sensitivity to glucocorticoid evaluated by urinary
trypsin inhibitor excretion. Proc Soc Exp Biol Med. 120:338–340.
1965. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Ueki M, Yokono S, Taie S, Nogaya J,
Komatsu H and Ogli K: Changes of urinary ulinastatin and serum CRP
after elective surgery for gastric cancer. Masui. 45:933–936.
1996.(In Japanese).
|
|
31
|
Pugia MJ and Lott JA: Pathophysiology and
diagnostic value of urinary trypsin inhibitors. Clin Chem Lab Med.
43:1–16. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Yamashita Y, Shimada M, Hamatsu T, et al:
Effects of preoperative steroid administration on surgical stress
in hepatic resection: prospective randomized trial. Arch Surg.
136:328–333. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Shirabe K, Takenaka K, Yamatomto K, et al:
Impaired systemic immunity and frequent infection in patients with
Candida antigen after hepatectomy. Hepatogastroenterology.
44:199–204. 1997.PubMed/NCBI
|
|
34
|
Shimada H, Ochiai T, Okazumi S, et al:
Clinical benefits of steroid therapy on surgical stress in patients
with esophageal cancer. Surgery. 128:791–798. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Aldrighetti L, Pulitano C, Arru M, et al:
Impact of preoperative steroid administration on
ischemia-reperfusion injury and systemic responses in liver
surgery: a prospective randomized study. Liver Transpl. 12:941–949.
2006. View
Article : Google Scholar
|
